Citi’s 13th Annual Biotech Conference on September 5-6 in Boston
- Citi’s 13th Annual Biotech Conference on September 5-6 in Boston
- Morgan Stanley 16th Annual Global Healthcare Conference on September 12-14 in New York City
- Jefferies Gene Therapy Summit on September 27 in New York City
SAN RAFAEL, Calif., Aug. 22, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in three investor conferences this September. To access the events that are accessible by live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company’s portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin’s website is not incorporated by reference into this press release.
Contacts: Investors Media Traci McCarty Debra Charlesworth BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc. (415) 455-7558 (415) 455-7451
View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-investor-conferences-in-september-300700672.html
SOURCE BioMarin Pharmaceutical Inc.
Company Codes: NASDAQ-NMS:BMRN
